Home
TNXP
TNXP News

Latest Tonix Pharmaceuticals Holding Corp. (TNXP) News on July 27, 2024

MT Newswires

a day ago

Tonix Pharmaceuticals Gets FDA Fast Track Label For Tonmya; Shares Rise

Tonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmya™ for Fibromyalgia

GlobeNewswire

2 days ago

Tonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmya™ for Fibromyalgia

MT Newswires

2 days ago

Tonix Pharmaceuticals Signs Deal with US Defense Department to Develop Antiviral Drugs

Beyond "One Bug, One Drug" - Tonix Pharmaceuticals Secures Up To $34 Million In Funding From The U.S. Department Of Defense To Develop a Broad-Spectrum Antiviral

ACCESSWIRE

3 days ago

Beyond "One Bug, One Drug" - Tonix Pharmaceuticals Secures Up To $34 Million In Funding From The U.S. Department Of Defense To Develop a Broad-Spectrum Antiviral

TNXP: High Interest in Tonmya Seen in Initial Findings from Market Opportunity Analysis…

Zacks Small Cap Research

8 days ago

TNXP: High Interest in Tonmya Seen in Initial Findings from Market Opportunity Analysis…

ACCESSWIRE

10 days ago

Tonix Pharmaceuticals, Set to File an NDA for Tonmya for the Management of Fibromyalgia, is Planning Expected Launch in 2H 2025

Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering

GlobeNewswire

16 days ago

Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering

MT Newswires

17 days ago

Tonix Pharmaceuticals Prices $4 Million Public Offering; Shares Plunge

Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering

GlobeNewswire

17 days ago

Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering

MT Newswires

18 days ago

Tonix Pharmaceuticals Plans Stock Offering; Shares Fall After-Hours

Tonix Pharmaceuticals Announces Proposed Public Offering

GlobeNewswire

18 days ago

Tonix Pharmaceuticals Announces Proposed Public Offering

MT Newswires

18 days ago

Tonix Pharmaceuticals Gets FDA Nod to Proceed With New Drug Application for Tonmya in Fibromyalgia

Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya™ for the Management of Fibromyalgia

GlobeNewswire

19 days ago

Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya™ for the Management of Fibromyalgia

Nano-Cap Tonix Pharmaceuticals Secures Large US Department of Defense Contract

Benzinga

25 days ago

Nano-Cap Tonix Pharmaceuticals Secures Large US Department of Defense Contract

Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program

GlobeNewswire

a month ago

Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program

MT Newswires

a month ago

Tonix Pharmaceuticals Closes $4 Million Offering

Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering

GlobeNewswire

a month ago

Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering

MT Newswires

a month ago

Top Midday Decliners

Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering

GlobeNewswire

a month ago

Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering

Tonix Pharmaceuticals Announces Proposed Public Offering

GlobeNewswire

a month ago

Tonix Pharmaceuticals Announces Proposed Public Offering

MT Newswires

a month ago

Tonix Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Rule

Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire

a month ago

Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024

GlobeNewswire

a month ago

Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024

Tonix Pharmaceuticals Announces Positive Pre-NDA CMC Meeting with FDA for Tonmya™ for the Management of Fibromyalgia

GlobeNewswire

a month ago

Tonix Pharmaceuticals Announces Positive Pre-NDA CMC Meeting with FDA for Tonmya™ for the Management of Fibromyalgia

Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS)

GlobeNewswire

a month ago

Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS)

Tonix Pharmaceuticals Presented Poster of Tonmya™ for the Management of Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2024

GlobeNewswire

a month ago

Tonix Pharmaceuticals Presented Poster of Tonmya™ for the Management of Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2024

Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering

GlobeNewswire

a month ago

Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering

MT Newswires

a month ago

Top Midday Decliners

Tonix Pharmaceuticals Announces Pricing of $4.0 Million Public Offering

GlobeNewswire

a month ago

Tonix Pharmaceuticals Announces Pricing of $4.0 Million Public Offering

MT Newswires

a month ago

Tonix Pharmaceuticals Plans Common Stock Offering to Fund New Drug Application for Fibromyalgia; Shares Fall After Hours

Tonix Pharmaceuticals Announces Proposed Public Offering

GlobeNewswire

a month ago

Tonix Pharmaceuticals Announces Proposed Public Offering

Edge Total Intelligence Inc. Updates Status of MCTO

Newsfile

2 months ago

Edge Total Intelligence Inc. Updates Status of MCTO

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

GlobeNewswire

2 months ago

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting

GlobeNewswire

2 months ago

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

CNW Group

2 months ago

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

CNW Group

2 months ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers

GlobeNewswire

2 months ago

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024

GlobeNewswire

2 months ago

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

PR Newswire

2 months ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

PR Newswire

2 months ago

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

Enhancing the Power of PTZs: Canon Announces New PTZ Firmware Updates Lending Greater Control and Operability, Including an Auto-Tracking Lite Version on Compatible PTZ Models*

GlobeNewswire

2 months ago

Enhancing the Power of PTZs: Canon Announces New PTZ Firmware Updates Lending Greater Control and Operability, Including an Auto-Tracking Lite Version on Compatible PTZ Models*

Business Wire

2 months ago

Form 8.3 - International Distribution Services plc

Business Wire

2 months ago

Form 8.3 - Darktrace plc

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Reuters

2 months ago

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

Investor's Business Daily

2 months ago

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

GlobeNewswire

2 months ago

Middlefield Canadian Income PCC: Net Asset Value(s)

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

Business Wire

2 months ago

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

MT Newswires

2 months ago

Tonix Pharmaceuticals to Implement 1-for-32 Reverse Stock Split -- Shares Fall

Tonix Pharmaceuticals Announces 1-for-32 Reverse Stock Split

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Announces 1-for-32 Reverse Stock Split

Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024

Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2024

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2024

Tonix Pharmaceuticals Presented New Data on Tonmya™ Suggesting Activity for Improvement in Fibromyalgia-Associated Depression Severity in an Oral Presentation at ASCP Annual Meeting

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Presented New Data on Tonmya™ Suggesting Activity for Improvement in Fibromyalgia-Associated Depression Severity in an Oral Presentation at ASCP Annual Meeting

Tonix Pharmaceuticals Announces Two Poster Presentations of TNX-102 SL (Sublingual Cyclobenzaprine HCl) at the ASCP Annual Meeting

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Announces Two Poster Presentations of TNX-102 SL (Sublingual Cyclobenzaprine HCl) at the ASCP Annual Meeting

Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024

Tonix Pharmaceuticals Announces Presentation at the 2024 BIO International Convention

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Announces Presentation at the 2024 BIO International Convention

Tonix Pharmaceuticals to Deliver an Oral Presentation and Present Two Posters at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

GlobeNewswire

2 months ago

Tonix Pharmaceuticals to Deliver an Oral Presentation and Present Two Posters at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVERSANA Market Opportunity Analysis for Tonmya™ for the Management of Fibromyalgia

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVERSANA Market Opportunity Analysis for Tonmya™ for the Management of Fibromyalgia

Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase

GlobeNewswire

2 months ago

Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase

Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights

ACCESSWIRE

3 months ago

Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV

TNXP: Approval of First New Fibromyalgia Drug in 15 Years Possible in 2025…

Zacks Small Cap Research

3 months ago

TNXP: Approval of First New Fibromyalgia Drug in 15 Years Possible in 2025…

Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase

GlobeNewswire

3 months ago

Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

GlobeNewswire

4 months ago

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering

GlobeNewswire

4 months ago

Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering

Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome

GlobeNewswire

4 months ago

Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome

Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 Meeting

GlobeNewswire

4 months ago

Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 Meeting

Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya™ for the Management of Fibromyalgia

GlobeNewswire

4 months ago

Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya™ for the Management of Fibromyalgia

Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on April 1, 2024

GlobeNewswire

4 months ago

Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on April 1, 2024

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring

TNXP: Tonmya™ May Launch Alongside Another New Fibromyalgia Treatment…

Zacks Small Cap Research

5 months ago

TNXP: Tonmya™ May Launch Alongside Another New Fibromyalgia Treatment…

Tonix Pharmaceuticals Reports Improvement in “Brain Fog,” in Fibromyalgia Patients Treated with Tonmya™ in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in Fibromyalgia

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Reports Improvement in “Brain Fog,” in Fibromyalgia Patients Treated with Tonmya™ in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in Fibromyalgia

New to The Street Announces TV Episode 560 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV Tonight, Thursday, March 7, 2024, at 9:30 PM PT

GlobeNewswire

5 months ago

New to The Street Announces TV Episode 560 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV Tonight, Thursday, March 7, 2024, at 9:30 PM PT

Tonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-102 SL on PTSD Symptoms and Sleep Quality in Military-Related PTSD at Four Weeks of Therapy

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-102 SL on PTSD Symptoms and Sleep Quality in Military-Related PTSD at Four Weeks of Therapy

Tonix Pharmaceuticals Selects EVERSANA® to Support Launch Strategy and Commercialization Planning of Tonmya™ for the Management of Fibromyalgia

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Selects EVERSANA® to Support Launch Strategy and Commercialization Planning of Tonmya™ for the Management of Fibromyalgia

Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (Fc-modified humanized anti-CD40L mAb) Supports Monthly i.v. Dosing in Humans

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (Fc-modified humanized anti-CD40L mAb) Supports Monthly i.v. Dosing in Humans

Tonix Pharmaceuticals Announces Presentation at The 6th International Congress on Controversies in Fibromyalgia

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces Presentation at The 6th International Congress on Controversies in Fibromyalgia

Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy Volunteers

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy Volunteers

Tonix Pharmaceuticals drug TNX-102 SL gets FDA ok for US Department of Defense funded trial

News Direct

5 months ago

Tonix Pharmaceuticals drug TNX-102 SL gets FDA ok for US Department of Defense funded trial

Tonix Pharmaceuticals' Fibromyalgia Trial Shows Promising Results in Webinar Presentation

News Direct

5 months ago

Tonix Pharmaceuticals' Fibromyalgia Trial Shows Promising Results in Webinar Presentation

Tonix Pharmaceuticals Announces Positive Results from Clinical Pharmacokinetic Bridging Study of Tonmya™ to Support Development and Partnering in Japan and China

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces Positive Results from Clinical Pharmacokinetic Bridging Study of Tonmya™ to Support Development and Partnering in Japan and China

New Drug Study Shows Improving Sleep Quality Can Relieve Fibromyalgia Pain

ACCESSWIRE

5 months ago

New Drug Study Shows Improving Sleep Quality Can Relieve Fibromyalgia Pain

3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond

InvestorPlace

5 months ago

3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond

New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series

GlobeNewswire

5 months ago

New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series

Tonix Pharmaceuticals to Participate in the 2024 BIO CEO & Investor Conference

GlobeNewswire

5 months ago

Tonix Pharmaceuticals to Participate in the 2024 BIO CEO & Investor Conference

New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PT

GlobeNewswire

5 months ago

New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PT

Tonix Drug Shown To Relieve Pain in Fibromyalgia Without Risk of Addiction

ACCESSWIRE

5 months ago

Tonix Drug Shown To Relieve Pain in Fibromyalgia Without Risk of Addiction

Tonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3 Fibromyalgia Trial for Tonmya™, Plans to File NDA for FDA Approval in Second Half of 2024

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3 Fibromyalgia Trial for Tonmya™, Plans to File NDA for FDA Approval in Second Half of 2024

Tonix Pharmaceuticals Announces Engagement of Rho as CRO to Support Submission of New Drug Application to the FDA for Approval of Tonmya™ for the Management of Fibromyalgia

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces Engagement of Rho as CRO to Support Submission of New Drug Application to the FDA for Approval of Tonmya™ for the Management of Fibromyalgia

Tonix Pharmaceuticals Announces FDA IND Clearance for DoD Funded Trial of TNX-102 SL for the Reduction of Acute Stress Reaction and Prevention of PTSD

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces FDA IND Clearance for DoD Funded Trial of TNX-102 SL for the Reduction of Acute Stress Reaction and Prevention of PTSD

VIVEON HEALTHCARE ACQUISITION CORP CONFIRMS BUSINESS COMBINATION

GlobeNewswire

6 months ago

VIVEON HEALTHCARE ACQUISITION CORP CONFIRMS BUSINESS COMBINATION

New Hope For Fibromyalgia Patients: Tonix Details Results Of Second Successful Phase 3 Trial And Plans To File For FDA Approval

ACCESSWIRE

6 months ago

New Hope For Fibromyalgia Patients: Tonix Details Results Of Second Successful Phase 3 Trial And Plans To File For FDA Approval

Tonix Pharmaceuticals Announces Research Indicating Pre-Existing Fibromyalgia-Type Symptoms May Increase the Risk of Developing Long COVID

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces Research Indicating Pre-Existing Fibromyalgia-Type Symptoms May Increase the Risk of Developing Long COVID

20 Countries With The Highest Number of Drug Trafficking in the World

Insider Monkey

6 months ago

20 Countries With The Highest Number of Drug Trafficking in the World

Tonix Pharmaceuticals Announces Conditional Acceptance of Tonmya™ as Trade Name for TNX-102 SL for the Management of Fibromyalgia

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces Conditional Acceptance of Tonmya™ as Trade Name for TNX-102 SL for the Management of Fibromyalgia

Best Drug and Alcohol Rehab Centers in Each of 30 Biggest Cities in the US

Insider Monkey

6 months ago

Best Drug and Alcohol Rehab Centers in Each of 30 Biggest Cities in the US

Yoshitsu Co., Ltd. Announces Pricing of $4.0 Million Registered Direct Offering and Private Placement

GlobeNewswire

6 months ago

Yoshitsu Co., Ltd. Announces Pricing of $4.0 Million Registered Direct Offering and Private Placement

Tonix Pharmaceuticals Announces KOL Webinar to Discuss Positive Phase 3 Fibromyalgia Data, Sponsored by A.G.P.

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces KOL Webinar to Discuss Positive Phase 3 Fibromyalgia Data, Sponsored by A.G.P.

Tonix Study Reveals Promising Fibromyalgia Treatment

Exec Edge

6 months ago

Tonix Study Reveals Promising Fibromyalgia Treatment

TNXP: Positive Results for Phase 3 RESILIENT Trial Sets Up NDA Filing in 2H24…

Zacks Small Cap Research

6 months ago

TNXP: Positive Results for Phase 3 RESILIENT Trial Sets Up NDA Filing in 2H24…

Freshpet, Tilly’s, and More Stocks See Action From Activist Investors

Barrons.com

6 months ago

Freshpet, Tilly’s, and More Stocks See Action From Activist Investors

Share on Social Networks: